Last reviewed · How we verify

NCT03678116

Effects of a Thermogenic Dietary Supplement on Metabolic, Hemodynamic, and Mood Responses

Completed NA Last updated 28 March 2019
What this trial tests

NA trial testing Sugar Pill (placebo) in Energy Metabolism in 14 participants. Completed in 31 October 2018.

Timeline
23 July 2018
Primary endpoint
31 October 2018
31 October 2018

Quick facts

Lead sponsorUniversity of Mary Hardin-Baylor
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposeother
Enrollment14
Start date23 July 2018
Primary completion31 October 2018
Estimated completion31 October 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Mary Hardin-Baylor

Who can join

Adults 18 to 35, any sex, with Energy Metabolism or Heart Rate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This a randomized, double blind, placebo controlled, crossover design study which measures the effect of an available thermogenic dietary supplement on resting energy expenditure (REE), blood pressure and heart rate, and mood changes in moderate caffeine consumers. Participants will complete baseline measurements then ingest one of three pills. Once the pill is ingested, subjects will complete four REEs along with heart rate and blood pressure and appropriate questionnaires. Participants will return two more times, each after a one week washout period, and complete the same protocol with the remaining supplements.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Energy Metabolism

Currently open trials in the same condition.

Other University of Mary Hardin-Baylor trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03678116.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing